New chapter in the history of preventive medicine and diagnostic methods begins. One of the good news, our Igloo device has gone on sale. Everyone can order it.
The main problem of typical lateral flow assays readers is the low quality of tests and detection, high price of devices and teeerrible UX. We fixed all these shortcomings through the introduction of computer vision and time-resolve fluorescence, as well as made support for almost any test manufacturers - one instrument for all lateral flow assays (LFA).
So far, about 10 biomarkers are available, but soon we will expand them to 300. We are also developing scalable technology for LFA, named microarray, this is when there are about 10-40 biomarkers for 1 test cassette at once (successfully tested on Alex allergy panel).
For now, we are more focused on B2B in the EU and MENA market. You can see our devices in pharmacies in Italy, in schools in Qatar or fitness clubs in Turkey: and we do things that don't scale.
We finished YC startupschool and passed caelestinus healthtech incubator, got CE Mark and IVDD for medical products of Class A for the first device, and it's not Theranos ;)
So, we really need your upvotes and support, because it is so important for people's health!!
PS: Open to collaboration with biotech and healthtech company, biohackers and enthusiasts. Ready to answer any of your questions.
The main problem of typical lateral flow assays readers is the low quality of tests and detection, high price of devices and teeerrible UX. We fixed all these shortcomings through the introduction of computer vision and time-resolve fluorescence, as well as made support for almost any test manufacturers - one instrument for all lateral flow assays (LFA).
So far, about 10 biomarkers are available, but soon we will expand them to 300. We are also developing scalable technology for LFA, named microarray, this is when there are about 10-40 biomarkers for 1 test cassette at once (successfully tested on Alex allergy panel).
For now, we are more focused on B2B in the EU and MENA market. You can see our devices in pharmacies in Italy, in schools in Qatar or fitness clubs in Turkey: and we do things that don't scale.
We finished YC startupschool and passed caelestinus healthtech incubator, got CE Mark and IVDD for medical products of Class A for the first device, and it's not Theranos ;)
So, we really need your upvotes and support, because it is so important for people's health!!
PS: Open to collaboration with biotech and healthtech company, biohackers and enthusiasts. Ready to answer any of your questions.